DMRA — DAMORA THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 106 家机构在其最新 13F 申报中持有 DMRA(DAMORA THERAPEUTICS INC),合计申报市值 $1.66B,对应 64.10M 股。按股数计算较上季度增持 8.4%(+4.39M 股),申报市值环比上升 8.9%。持仓集中度较高:前五大持有人占申报市值的 44.6%,前十大的集中度为 62.5%。
与上一季度相比,56 家新建仓位、23 家加仓、9 家减仓、14 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
DAMORA THERAPEUTICS INC(DMRA)的主要机构持有人包括 Fairmount Funds Management LLC、Fidelity Management & Research (FMR)、Avoro Capital Advisors LLC,按 13F 申报市值在本页 158 家持有人中排名居前。
DMRA 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
持有 DMRA 的传奇投资人
我们追踪的超级投资人在各自最新 13F 申报中持有 DMRA 的名单——每位投资人按其自身最近一个季度展示。
| 投资人 | 季度 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|---|
|
|
Q2 2026 | 2.31M | $60.11M | 0.17% | 持有 |
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 65 | 25.33M | $537.80M | +13.7% |
| Q2 2026 | 106 | 64.10M | $1.66B | +8.4% |
| Q1 2026 | 64 | 56.00M | $1.45B | +1559.7% |
| Q4 2025 | 22 | 1.26M | $98.46M | +44.4% |
| Q3 2025 | 15 | 233.50K | $6.69M | -7.4% |
| Q2 2025 | 11 | 189.76K | $3.23M | +44.3% |
| Q1 2025 | 12 | 144.50K | $480.37K | -8.2% |
| Q4 2024 | 11 | 5.14M | $860.65K | +0.0% |
表内 8 个季度中,机构持股合计增加 393%(Q4 2024 → Q3 2026);单季变动最大的是 Q1 2026(+1559.7%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.55M | $203.20M | 0.01% | 增持 | |
| 3.51M | $74.79M | 0.00% | 增持 | |
| 2.05M | $43.53M | 15.91% | 持有 | |
| 1.87M | $38.69M | 0.00% | 减持 | |
| 1.78M | $37.90M | 0.00% | 增持 | |
| 1.20M | $25.61M | 0.00% | 增持 | |
| 1.08M | $23.04M | 0.01% | 增持 | |
| 900.00K | $19.15M | 0.46% | 持有 | |
| 557.50K | $11.86M | 0.00% | 增持 | |
| 375.68K | $7.99M | 0.00% | 增持 | |
| 375.00K | $7.98M | 0.37% | 减持 | |
| 304.51K | $6.48M | 0.00% | 增持 | |
| 278.00K | $5.92M | 0.27% | 持有 | |
| 223.85K | $4.76M | 0.01% | 新进 | |
| 205.52K | $4.37M | 0.01% | 新进 | |
| 143.75K | $3.06M | 0.00% | 减持 | |
| 141.51K | $3.01M | 0.00% | 减持 | |
| 139.00K | $2.96M | 2.23% | 持有 | |
| 95.22K | $2.03M | 0.00% | 减持 | |
| 63.49K | $1.35M | 0.00% | 减持 | |
| 61.46K | $1.31M | 0.01% | 新进 | |
| 52.90K | $1.13M | 0.00% | 减持 | |
| 39.41K | $838.64K | 0.00% | 增持 | |
| 31.41K | $668.45K | 0.00% | 增持 | |
| 31.31K | $666.26K | 0.00% | 减持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.23M | $240.15M | 0.01% | 增持 | |
| 8.71M | $226.63M | 14.98% | 持有 | |
| 3.78M | $98.40M | 0.88% | 持有 | |
| 3.60M | $93.73M | 2.84% | 持有 | |
| 3.16M | $82.25M | 0.00% | 增持 | |
| 2.44M | $63.49M | 8.46% | 持有 | |
| 2.40M | $62.42M | 0.54% | 持有 | |
| 2.31M | $60.11M | 0.17% | 持有 | |
| 2.28M | $59.28M | 0.03% | 新进 | |
| 2.05M | $53.20M | 11.78% | 持有 | |
| 1.94M | $50.43M | 3.00% | 持有 | |
| 2.06M | $49.85M | 0.01% | 新进 | |
| 1.62M | $42.15M | 1.66% | 增持 | |
| 1.62M | $42.11M | 0.89% | 减持 | |
| 1.24M | $32.15M | 0.23% | 持有 | |
| 1.23M | $31.97M | 0.10% | 减持 | |
| 1.22M | $31.81M | 0.51% | 持有 | |
| 1.06M | $27.52M | 0.01% | 持有 | |
| 1.00M | $26.09M | 0.07% | 增持 | |
| 1.00M | $26.01M | 1.33% | 减持 | |
| 965.36K | $25.11M | 0.00% | 新进 | |
| 965.36K | $25.11M | 0.00% | 增持 | |
| 900.00K | $23.41M | 0.47% | 持有 | |
| 840.29K | $21.86M | 0.01% | 增持 | |
| 575.00K | $14.96M | 0.35% | 减持 |
Q1 2026 — 25 家基金
Q4 2025 — 22 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.74K | $40.01M | 0.02% | 新进 | |
| 76.90K | $16.99M | 2.17% | 新进 | |
| 41.10K | $9.08M | 0.05% | 增持 | |
| 31.30K | $6.91M | 0.09% | 减持 | |
| 285.71K | $6.57M | 0.76% | 新进 | |
| 238.88K | $5.50M | 0.00% | 新进 | |
| 120.57K | $2.77M | 0.03% | 新进 | |
| 120.47K | $2.77M | 1.63% | 新进 | |
| 109.00K | $2.51M | 0.01% | 新进 | |
| 95.80K | $2.20M | 0.06% | 新进 | |
| 74.92K | $1.72M | 0.00% | 新进 | |
| 18.25K | $419.86K | 0.00% | 新进 | |
| 14.50K | $333.64K | 0.01% | 新进 | |
| 11.57K | $266.35K | 0.00% | 新进 | |
| 7.52K | $173.03K | 0.00% | 增持 | |
| 6.39K | $147.01K | 0.00% | 增持 | |
| 1.23K | $28.26K | 0.00% | 减持 | |
| 1.13K | $25.93K | 0.00% | 增持 | |
| 1 | $15.85K | 0.00% | 新进 | |
| 176 | $4.05K | 0.00% | 减持 | |
| 25 | $575 | 0.00% | 新进 | |
| 14 | $322 | 0.00% | 减持 |
Q3 2025 — 15 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 33.20K | $3.18M | 0.04% | 增持 | |
| 20.20K | $1.93M | 0.01% | 减持 | |
| 9.90K | $948.02K | 0.35% | 新进 | |
| 86.58K | $322.07K | 0.02% | 减持 | |
| 26.96K | $100.28K | 0.09% | 新进 | |
| 20.30K | $75.50K | 0.00% | 新进 | |
| 15.04K | $55.96K | 0.00% | 增持 | |
| 13.13K | $49.00K | 0.00% | 新进 | |
| 6.50K | $24.18K | 0.00% | 增持 | |
| 1.43K | $5.31K | 0.00% | 增持 | |
| 100 | $372 | 0.00% | 持有 | |
| 59 | $220 | 0.00% | 减持 | |
| 55 | $205 | 0.00% | 减持 | |
| 43 | $160 | 0.00% | 新进 | |
| 18 | $67 | 0.00% | 持有 |
Q2 2025 — 11 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 52.50K | $2.56M | 0.01% | 增持 | |
| 99.91K | $340.70K | 0.02% | 持有 | |
| 4.50K | $219.19K | 0.00% | 增持 | |
| 14.54K | $49.59K | 0.00% | 减持 | |
| 13.60K | $45.16K | 0.00% | 增持 | |
| 2.31K | $7.89K | 0.00% | 增持 | |
| 1.23K | $4.19K | 0.00% | 持有 | |
| 942 | $3.21K | 0.00% | 减持 | |
| 100 | $341 | 0.00% | 减持 | |
| 100 | $341 | 0.00% | 减持 | |
| 18 | $61 | 0.00% | 持有 |
新建仓(Q2 2026)
- Jupiter Topco LLC 2.28M 股 · $59.28M
- JPMorgan Chase & Co 2.06M 股 · $49.85M
- GEODE CAPITAL MANAGEMENT, LLC 965.36K 股 · $25.11M
- VANGUARD PORTFOLIO MANAGEMENT LLC 365.50K 股 · $9.51M
- STEMPOINT CAPITAL LP 216.19K 股 · $5.62M
- Citadel Advisors 166.35K 股 · $4.33M
- BNY Mellon 151.02K 股 · $3.93M
- Nuveen, LLC 149.59K 股 · $3.89M
- Sixth Street Partners Management Company, L.P. 142.14K 股 · $3.70M
- DV EQUITIES, LLC 130.00K 股 · $3.38M
- Swiss National Bank 72.60K 股 · $1.89M
- RHUMBLINE ADVISERS 65.83K 股 · $1.71M
完全清仓(较上季)
- Janus Henderson Group 卖出 2.36M 股 · $61.44M
- MILLENNIUM MANAGEMENT LLC 卖出 471.65K 股 · $12.22M
- Qube Research & Technologies Ltd 卖出 282.44K 股 · $7.32M
- STATE STREET CORP 卖出 183.92K 股 · $4.76M
- Marshall Wace 卖出 169.82K 股 · $4.40M
- BOOTHBAY FUND MANAGEMENT, LLC 卖出 110.44K 股 · $2.86M
- Hudson Bay Capital Management LP 卖出 76.34K 股 · $1.98M
- Brevan Howard Capital Management LP 卖出 55.23K 股 · $1.43M
- LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 卖出 24.46K 股 · $633.41K
- Catalyst Funds Management Pty Ltd 卖出 17.29K 股 · $447.89K
- JANE STREET GROUP, LLC 卖出 11.42K 股 · $295.78K
- Schonfeld Strategic Advisors LLC 卖出 10.82K 股 · $280.34K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 9.55M | 9.23M | 9.05M | 238.88K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 3.51M | 3.16M | 222.44K | 7.52K | 100 | 100 | 490 | 490 | 490 | — | — | — | — | — | — | — | — | — | — | — |
| Remedium Capital Partners, LLC | 2.05M | 2.05M | 2.05M | 120.47K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 1.87M | 2.06M | — | — | — | — | — | 100 | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 1.78M | — | 183.92K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.20M | 965.36K | 241.13K | 11.57K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 1.08M | 840.29K | 160.41K | 6.39K | 59 | 2.31K | 285 | 12.47K | 5.10K | — | — | — | — | — | — | — | — | — | — | — |
| Siren, L.L.C. | 900.00K | 900.00K | 900.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 557.50K | 212.60K | 201.85K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 375.68K | 365.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 375.00K | 425.00K | 450.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 304.51K | 141.83K | 96.66K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | 278.00K | 278.00K | 278.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Marshall Wace | 223.85K | — | 169.82K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BANK OF MONTREAL /CAN/ | 205.52K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 143.75K | 151.02K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nuveen, LLC | 141.51K | 149.59K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Kalehua Capital Management LLC | 139.00K | 139.00K | 139.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 95.22K | 119.03K | 96.78K | 74.92K | — | — | — | 100 | 160 | — | — | — | — | — | — | — | — | — | — | — |
| RHUMBLINE ADVISERS | 63.49K | 65.83K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold DMRA?
As of 2026-Q2, 106 institutional funds reported holding DMRA (DAMORA THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $1.66B.
How many shares of DMRA do institutions own?
13F filers reported 64.10M shares of DMRA, worth $1.66B in aggregate at the end of 2026-Q2.
Is institutional ownership of DMRA rising or falling?
Share counts moved +8.4% versus the prior quarter — accumulation.
Who are the top institutional holders of DMRA?
The largest 13F holders are Fairmount Funds Management LLC, Fidelity Management & Research (FMR), Avoro Capital Advisors LLC, Venrock Adviser, LLC, BlackRock Inc; the top 25 are ranked at the top of this page.
Who are the major shareholders of DAMORA THERAPEUTICS INC?
The major shareholders of DAMORA THERAPEUTICS INC (DMRA) by reported 13F value are Fairmount Funds Management LLC, Fidelity Management & Research (FMR), Avoro Capital Advisors LLC, Venrock Adviser, LLC, BlackRock Inc, among 158 institutional holders.
Which legendary investors own DMRA?
1 of the legendary investors tracked on HoldingsHub report DMRA (DAMORA THERAPEUTICS INC) in their latest 13F filings, led by Viking Global Investors. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on DMRA?
1 tracked superinvestors hold DMRA simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.